Figure 2.
Kaplan Meier estimates of (A) PFS and (B) OS by pre-treatment prognostic groups for HER2-positive ABC patients who received first-line pertuzumab, trastuzumab and docetaxel within CLEOPATRA.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.